VF
TARO

Virtu Financial’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Virtu Financial’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-3,950
Closed -$414K – 2753
2017
Q4 		$414K Buy
+3,950
New +$434K 0.02% 983

Other funds holding TARO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
FL
Fort LP Chevy Chase, Maryland $39.6M AUM 37.11% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Virtu Financial's TARO Position: Q1 2018 in Review

Virtu Financial sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2018, closing a stake of 3,950 shares — an estimated $414K sold.

Virtu Financial first reported a position in TARO in Q4 2017 and held it in 1 quarter. The position peaked at $414K in Q4 2017. 109 funds tracked by Wall St. Rank hold TARO as of Q1 2018.

  • Virtu Financial reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2018 after selling out during the quarter.
  • Virtu Financial sold 3,950 Taro Pharmaceutical Industries Ltd. shares in Q1 2018, an estimated $414K.
  • Virtu Financial first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2017 and held it in 1 quarter.
  • Virtu Financial's Taro Pharmaceutical Industries Ltd. position peaked at $414K in Q4 2017.
  • 109 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2018.

Based on Virtu Financial's 13F filing for Q1 2018, filed 14 May 2018.